PASITHEA THERAPEUTICS CORP KTTA
ASignal's systematic analysis rates KTTA as Bearish.
Reflects the latest available analysis · analyzed Nov 13, 2026
The case on KTTA
Bull vs bear, surfaced by ASignal's framework agents from public market data. The precise verdict: ASignal Rank, confidence, and price targets - is in the app.
- Strong cash position with $45.66M in total cash and no debt
- High current and quick ratios indicating strong short-term liquidity (26.25x and 24.84x)
- MACD above signal line with expanding histogram, indicating strengthening momentum
- Price trading above 20-day and 50-day moving averages
- Negative return on equity (-65.49%) and return on assets (-36.00%)
- Negative operating cash flow ($-17.78M) and free cash flow ($-12.17M)
- Enterprise value is negative ($-28.29M), suggesting weak capital structure
- Extremely low price-to-book (0.38x) may indicate distress rather than value
- Zero gross, operating, and net margins
- RSI at 69.38, approaching overbought territory
See the full verdict on KTTA
ASignal Rank (1-4), confidence score, Value / Activist / Macro grades, price targets, and the full reasoning behind the call.
How ASignal analyzes KTTA
Most investors never get a second opinion, let alone several. ASignal runs KTTA past a panel of specialized investor-framework agents, each calibrated on a distinct school of investing: value discipline, activist catalysts, and macro analysis. They don't just score in isolation, they argue: a dedicated Challenger agent pushes back on every conclusion until the panel settles on a reasoned consensus, weighing fundamentals, macro conditions, market sentiment, and price action together. The kind of cross-examined read that takes a research desk hours, ASignal delivers in under two minutes, refreshed every cycle.
The signal direction and the bull and bear case above are free. The precise read, ASignal Rank, framework grades, price targets, and full reasoning, stays with subscribers.